Search
for
Sort by
Research 121–150 of 1000+
- Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
- Plasmacytoid dendritic cells in alopecia areata: missing link?
- Sex hormone–binding globulin and risk of hyperglycemia in patients with androgenetic alopecia
- Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study
- Serum Androgens and Genetic Linkage Analysis in Early Onset Androgenetic Alopecia
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- Male pattern androgenetic alopecia in an Indian context: a perspective study
- Current understanding of androgenetic alopecia. Part I: etiopathogenesis.
- Alopecia: unapproved treatments or indications
- Prevalence and Etiology of Central Centrifugal Cicatricial Alopecia
- The Annual Changes of Clinical Manifestation of Androgenetic Alopecia Clinic in Korean Males and Females: A Outpatient-Based Study
- Topical Treatment of Extended Alopecia
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- A woman with iatrogenic androgenetic alopecia responding to finasteride
- Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
- Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
- Expression of anti-aging type-XVII collagen (COL17A1/BP180) in hair follicle-associated pluripotent (HAP) stem cells during differentiation
- trans-3,4'-Dimethyl-3-hydroxyflavanone, a Hair Growth Enhancing Active Component, Decreases Active Transforming Growth Factor .BETA.2 (TGF-.BETA.2) through Control of Urokinase-Type Plasminogen Activator (uPA) on the Surface of Keratinocytes
- Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
- Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
- Familial Androgenetic Alopecia in Siblings with Normal Endocrinological Status
- Pathomechanism of androgenetic alopecia and new treatment
- Type II Vitamin D Dependent Rickets: A Case Report
- Eficacia del tratamiento con inyecciones intradérmicas de plasma rico en plaquetas para la alopecia androgenética en varones: estudio de «antes-después»
- [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
- Alopecia areata in Black African patients: epidemiological, clinical, and therapeutic aspects
- The immunopathogenesis of Alopecia Areata
- The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids
- Pathomechanism of androgenetic alopecia and new treatment
- A New Era of 5α-Reductase Inhibitors for Androgenetic Alopecia